Literature DB >> 29752934

Postpartum hemorrhage outcomes and race.

Cynthia Gyamfi-Bannerman1, Sindhu K Srinivas2, Jason D Wright1, Dena Goffman1, Zainab Siddiq1, Mary E D'Alton1, Alexander M Friedman3.   

Abstract

BACKGROUND: How race is associated with adverse outcomes in the setting of postpartum hemorrhage is not well characterized.
OBJECTIVE: The objective of this study was to assess how race is associated with adverse maternal outcomes in the setting of postpartum hemorrhage. STUDY
DESIGN: This retrospective cohort study utilized the National (Nationwide) Inpatient Sample (NIS) from the Agency for Healthcare Research and Quality for the years 2012-2014. Women aged 15-54 years with a diagnosis of postpartum hemorrhage were included. Race and ethnicity were categorized as non-Hispanic white, non-Hispanic black, Hispanic, Asian or Pacific Islander, Native American, other, and unknown. Overall risk for severe morbidity based on Centers for Disease Control and Prevention criteria was analyzed along with risk for specific outcomes such as disseminated intravascular coagulation, hysterectomy, transfusion, and maternal death. Risk for severe morbidity was stratified by comorbid risk and compared by race. Weights were applied to create population estimates. Log-linear regression models were created to assess risk for severe morbidity with risk ratios and associated 95% confidence intervals as measures of effect.
RESULTS: A total of 360,370 women with postpartum hemorrhage from 2012 to 2014 were included in this analysis. Risk for severe morbidity was significantly higher among non-Hispanic black women (26.6%) than non-Hispanic white, Hispanic, or Asian or Pacific Islander women (20.7%, 22.5%, and 21.4%, respectively, P < .01). For non-Hispanic black compared with non-Hispanic white, Hispanic, and Asian or Pacific Islander women risk was higher for disseminated intravascular coagulation (8.4% vs 7.1%, 6.8%, and 6.8%, respectively, P < .01) and transfusion (19.4% vs 13.9%, 16.1%, and 15.8%, respectively, P < .01). Black women were also more likely than non-Hispanic white women to undergo hysterectomy (2.4% vs 1.9%, P < .01), although Asian or Pacific Islander women were at highest risk (2.9%). Adjusting for comorbidity, black women remained at higher risk for severe morbidity (P < .01). Risk for death for non-Hispanic black women was significantly higher than for nonblack women (121.8 per 100,000 deliveries, 95% confidence interval, 94.7-156.8 vs 24.1 per 100,000 deliveries, 95% confidence interval, 19.2-30.2, respectively, P < .01).
CONCLUSION: Black women were at higher risk for severe morbidity and mortality associated with postpartum hemorrhage.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  maternal risk; obstetric hemorrhage; racial disparities

Mesh:

Year:  2018        PMID: 29752934     DOI: 10.1016/j.ajog.2018.04.052

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  14 in total

1.  Cesarean birth and maternal morbidity among Black women and White women after implementation of a blended payment policy.

Authors:  Jonathan M Snowden; Sarah S Osmundson; Menolly Kaufman; Cori Blauer Peterson; Katy Backes Kozhimannil
Journal:  Health Serv Res       Date:  2020-07-16       Impact factor: 3.402

2.  Putting the "M" back in maternal-fetal medicine: A 5-year report card on a collaborative effort to address maternal morbidity and mortality in the United States.

Authors:  Mary E D'Alton; Alexander M Friedman; Peter S Bernstein; Haywood L Brown; William M Callaghan; Steven L Clark; William A Grobman; Sarah J Kilpatrick; Daniel F O'Keeffe; Douglas M Montgomery; Sindhu K Srinivas; George D Wendel; Katharine D Wenstrom; Michael R Foley
Journal:  Am J Obstet Gynecol       Date:  2019-03-05       Impact factor: 8.661

3.  Preeclampsia outcomes at delivery and race.

Authors:  Cynthia Gyamfi-Bannerman; Ambika Pandita; Eliza C Miller; Amelia K Boehme; Jason D Wright; Zainab Siddiq; Mary E D'Alton; Alexander M Friedman
Journal:  J Matern Fetal Neonatal Med       Date:  2019-02-20

4.  Safety and effectiveness of self-managed medication abortion provided using online telemedicine in the United States: A population based study.

Authors:  Abigail R A Aiken; Evdokia P Romanova; Julia R Morber; Rebecca Gomperts
Journal:  Lancet Reg Health Am       Date:  2022-02-17

5.  Associations of anaemia and race with peripartum transfusion in three United States datasets.

Authors:  Elisabeth Davis; Richard Amdur; Homa Ahmadzia
Journal:  Blood Transfus       Date:  2021-12-17       Impact factor: 5.752

6.  Maternal Morbidity Predicted by an Intersectional Social Determinants of Health Phenotype: A Secondary Analysis of the NuMoM2b Dataset.

Authors:  Elise N Erickson; Nicole S Carlson
Journal:  Reprod Sci       Date:  2022-03-21       Impact factor: 2.924

7.  Nonovert disseminated intravascular coagulation (DIC) in pregnancy: a new scoring system for the identification of patients at risk for obstetrical hemorrhage requiring blood product transfusion.

Authors:  Ali Alhousseini; Roberto Romero; Neta Benshalom-Tirosh; Dereje Gudicha; Percy Pacora; Dan Tirosh; Doron Kabiri; Lami Yeo; Jecko Thachil; Chaur-Dong Hsu; Sonia S Hassan; Offer Erez
Journal:  J Matern Fetal Neonatal Med       Date:  2020-02-03

8.  Racial/Ethnic Disparities in Intensive Care Admissions in a Pregnant and Postpartum Population, Hawai'i, 2012-2017.

Authors:  Pamela Estrada; Hyeong Jun Ahn; Scott A Harvey
Journal:  Public Health Rep       Date:  2021-06-07       Impact factor: 3.117

9.  Predicting Postpartum Hemorrhage After Vaginal Birth by Labor Phenotype.

Authors:  Elise N Erickson; Christopher S Lee; Nicole S Carlson
Journal:  J Midwifery Womens Health       Date:  2020-04-14       Impact factor: 2.891

10.  Preterm birth and nativity among Black women with gestational diabetes in California, 2013-2017: a population-based retrospective cohort study.

Authors:  Karen A Scott; Brittany D Chambers; Rebecca J Baer; Kelli K Ryckman; Monica R McLemore; Laura L Jelliffe-Pawlowski
Journal:  BMC Pregnancy Childbirth       Date:  2020-10-06       Impact factor: 3.007

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.